Introducing the Scientific Value Return Network

  ✓   Timely access to non-dilutive growth capital that is not debt
        Royalty interest financing provides access to capital in exchange for future revenue without the risks associated with debt, and serves as a compliment to equity financing activities
‍
  ✓   No impact to control or ownership of intellectual property
        Royalty obligations created and managed by SVRN leaves intellectual property in the hands of the existing owner(s) who maintain control over the requisite R&D and commercialization activities
‍
  ✓   Royalty terms and duration designed around capital needs
        Scope, duration, and terms of the royalty obligation are established based on capital needs, allowing for narrow collateral on specific products or IP assets

  ✓   Access exclusive royalty assets uncorrelated with macro volatility
        Scientific royalties are high-quality assets that generate predictable cash flows in sectors with inelastic demand such as medtech and biopharma, but have traditionally been accessible only for large institutional investors
‍
  ✓   Fractional investment opportunities enable portfolio diversification
        SVRN enables fractional ownership in scientific royalties allowing for flexible investment sizes for accredited investors and the opportunity to build a portfolio of cash-flowing assets that perform well in inflationary environments
‍
  ✓   Receive distributions from productive intellectual property
        SVRN allows investors to get direct exposure to revenue distributions from specific intellectual property in a manner that is distinct from traditional equity investment